PLUN — ProstaLund AB Share Price
Last trade - 00:00- SEK72.76m
- SEK51.21m
- SEK22.21m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.32 | ||
| Price to Tang. Book | 2.52 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.28 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -29.97% | ||
| Return on Equity | -35.08% | ||
| Operating Margin | -75.88% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 12.89 | 12.46 | 17.07 | 17.41 | 22.21 | n/a | n/a | 10.36% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
Directors
- Kerstin Jakobsson CHM (63)
- Johan Wennerholm PRE (52)
- Goran Dybner VPR (48)
- Anette Israelsson VPR (51)
- Sonny Schelin DRC (74)
- Maria Morin IND (47)
- Mikael Wahlgren IND (55)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 4th, 2007
- Public Since
- October 24th, 2013
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 76,588,737
- Address
- Scheelevagen 19, LUND, 223 63
- Web
- https://www.prostalund.se/
- Phone
- +46 46120908
- Auditors
- Ohrlings PricewaterhouseCoopers AB
Upcoming Events for PLUN
Similar to PLUN
Acarix AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Aegirbio AB
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 19:17 UTC, shares in ProstaLund AB are trading at SEK0.95. This share price information is delayed by 15 minutes.
Shares in ProstaLund AB last closed at SEK0.95 and the price had moved by -74.32% over the past 365 days. In terms of relative price strength the ProstaLund AB share price has underperformed the FTSE Global All Cap Index by -76.47% over the past year.
There is no consensus recommendation for this security.
ProstaLund AB does not currently pay a dividend.
ProstaLund AB does not currently pay a dividend.
ProstaLund AB does not currently pay a dividend.
To buy shares in ProstaLund AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK0.95, shares in ProstaLund AB had a market capitalisation of SEK72.76m.
Here are the trading details for ProstaLund AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: PLUN
Based on an overall assessment of its quality, value and momentum ProstaLund AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ProstaLund AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -62.63%.
As of the last closing price of SEK0.95, shares in ProstaLund AB were trading -48.28% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The ProstaLund AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
ProstaLund AB's management team is headed by:
- Kerstin Jakobsson - CHM
- Johan Wennerholm - PRE
- Goran Dybner - VPR
- Anette Israelsson - VPR
- Sonny Schelin - DRC
- Maria Morin - IND
- Mikael Wahlgren - IND